Navigation Links
Global Cholesterol Testing - Clinical Diagnostics
Date:1/3/2017

NEW YORK, Jan. 3, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Thousands of Cholesterol Tests by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 29 companies including many key and niche players such as -

Abbott Diagnostics, Inc.
AccuTech, LLC
Alere Inc.
Beckman Coulter, Inc.
Home Access Health Corporation

Read the full report: http://www.reportlinker.com/p04484194-summary/view-report.html

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 A. Lipid Panel Test/Complete Lipid Profile I-3 Total Cholesterol Test..............I-3 HDL Cholesterol Test..............I-3 LDL Cholesterol Testing..............I-3 Triglycerides/VLDL Cholesterol Testing I-4 B. Apolipoprotein B..............I-4 C. Other Apolipoprotein Tests I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Cholesterol Testing - An Overview II-1 Current & Future Analysis..............II-2 Increasing Healthcare Expenditure to Promote Testing Market II-2 Table 1: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart) II-3 Cholesterol Testing: Evolution from Invasive to Non-Invasive II-3 Developing Economies Offer Significant Potential II-4 Table 2: Healthcare Spending as Percentage of GDP in Select Developing Countries/Region (2014) (includes corresponding Graph/Chart).............. II-5

Table 3: Healthcare Spending as Percentage of GDP in Select Developed Countries for 2010, 2012 & 2014 (includes corresponding Graph/Chart)..............II-5

2. TRENDS, DRIVERS & CHALLENGES..............II-6 Global Menace of Cardiovascular Disease - Major Growth Factor II-6 Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart) II-6

Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).............. II-6

Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart) II-7

Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart) II-8

Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart) II-9 Lipid Panel Test - An Overview II-9 Preventive Healthcare Trend to Expand Growth II-10 Technological Advances to Improve Cholesterol Testing II-10 Cholesterol Testing With Smartphone II-11 Growing Smartphone Sales - A Business Case II-11 Table 9: Top Ten Countries by Mobile Phone Subscriptions in Millions and Penetration Rate (2015) (includes corresponding Graph/Chart).............. II-12

Table 10: Global Market for Smartphones: Volume Sales in Million Units for 2016, 2018 & 2020 (includes corresponding Graph/Chart).............. II-13 Non-Invasive Cholesterol Tests to Drive Demand II-13 Digital Photographs to Screen Cholesterol? II-14 Miniature Sensors - The Future of Cholesterol Testing II-14 Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers II-15 The Rise of C-reactive Protein Tests II-15 Global In-Vitro Diagnostics Market Signals Prospects II-15 Table 11: Global In-Vitro Diagnostics Market by Test Category (2017): Percentage Breakdown of Value Sales for Anatomic Pathology, Blood Screen Immunoassay, Coagulation, Hematology, Immunoassay, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, and Others (includes corresponding Graph/Chart).............. II-17

Table 12: Global In-Vitro Diagnostics Market by Sector (2017): Percentage Breakdown of Revenues for Decentralized & Patient Self-Testing, and Hospital & Commercial Laboratories (includes corresponding Graph/Chart) II-17

Table 13: Global In-Vitro Diagnostics Market by Geographic Region (2015): Percentage Breakdown of Value Sales for the United States, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart) II-18 Opportunities and Challenges in Self-Testing Industry II-18 An Evolving Market Enabled by Technology II-18 Cardiac IVD Market Offers Potential II-19 Point of Care Testing: Potential Opportunities Ahead II-19 Point of Care Diagnostics - An Overview II-20 Complexities in the POC Diagnostics Market II-20 POC Cholesterol Testing..............II-21 Aging Population - A Vital Demography for Cholesterol Testing II-21 Table 14: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (mid-2016) (includes corresponding Graph/Chart) II-22

Table 15: Global Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)..............II-23 Risk of CVD in Obesity Offers Prospects for Cholesterol Testing II-23 Table 16: Global Obese Population in Millions by Region/ Country (2413) (includes corresponding Graph/Chart) II-24 Table 17: Global Obesity Levels (2013): Percentage Share Breakdown of Total Obese Population by Leading Countries (includes corresponding Graph/Chart) II-25 Diabetics at Higher Risk of Heart Diseases II-25 Table 18: Worldwide Prevalence of Diabetes Mellitus by Geographic Region (2013 & 2035P) (includes corresponding Graph/Chart).............. II-26 The Hypertension-Cholesterol Link to Drive Demand II-26 Table 19: Death Rates Due to Hypertension in Select Countries II-27

Table 20: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 & 2010) (includes corresponding Graph/Chart) II-28 E-Retailing Drives Demand for Home Test Kits II-28 Table 21: Factors Influencing Online Purchase Decision - Percentage Share Breakdown of Consumer Preferences by Criteria (includes corresponding Graph/Chart) II-29

3. AN INSIGHT INTO CARDIOVASCULAR DISEASES II-30 The Heart of Heart Problems..............II-30 Types of Cardiovascular Diseases/Disorders II-30 Coronary Artery Disease..............II-30 Hyperlipidemia - An Important Risk Factor of Heart Disease II-30 Hypertension - The Silent Killer II-31 Two-Pronged Approach to Counter CVD II-32 Cardiovascular Risk Assessment II-32 Reality Check.............. II-32

4. GOOD & BAD OF CHOLESTEROL..............II-33 Blood Cholesterol - The Principal Cardiac Risk Marker II-33 Types of Cholesterol..............II-33 Total Cholesterol (TC)..............II-33 High Density Lipoprotein (HDL)..............II-33 Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL).............. II-34 Triglycerides (TRG)..............II-34 Glucose (GLU).............. II-34 Alanine Aminotransferase (ALT)..............II-34 Outcomes of High Blood Cholesterol II-34 Atherosclerosis.............. II-34 Coronary Heart Disease (CHD)..............II-34 Risk Factors and Risk Levels..............II-34 Risk Factors.............. II-34 Risk Levels.............. II-35 Risk Level Based on Total Cholesterol Concentration II-35 LDL-Cholesterol Risk Levels..............II-35 HDL-Cholesterol Risk Levels..............II-35 Triglyceride Risk Levels..............II-35

5. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES II-36 Cholesterol Testing.............. II-36 Need for Cholesterol Testing..............II-36 Candidates for Cholesterol Testing II-36 Test Procedure.............. II-37 Time of Testing - Crucial for Heart Disease Patients II-37 Types of Cholesterol Testing..............II-38 Lipid Panel Test/Lipid Profile II-38 Total Cholesterol Test..............II-38 HDL Cholesterol Test..............II-39 LDL Cholesterol Testing..............II-39 LDL Cholesterol Test - The First Cholesterol Testing Method II-39 Triglycerides/VLDL Cholesterol Testing II-40 Apolipoprotein B Test..............II-40 Other Cholesterol Tests..............II-40 Apolipoprotein A-1 Test..............II-40 ApoE Genotyping Test..............II-40 Apolipoprotein CII..............II-40 Other Key Markers for Cholesterol Testing II-41 RLP Cholesterol..............II-41 Non Instrumented Technologies II-41 Heart Disease Diagnosis Tests..............II-41 Non-Invasive Tests..............II-41 Invasive Tests.............. II-42 Other CVD Markers..............II-42 Creatine Kinase MB..............II-42 Troponin T and Troponin I..............II-42 Myoglobin.............. II-43 P-selectin Profile..............II-43 C-reactive Protein..............II-43 Endothelial Dysfunction..............II-44 Homocysteine.............. II-44 Plasminogen Activator Inhibitor-1 II-44 s-100 Protein.............. II-45 Thrombus Precursor Protein II-45 Other Cardiac Markers..............II-45

6. POINT OF CARE & HOME CHOLESTEROL TESTING II-46 Point of Care (POC) Medical Diagnostics II-46 Table 22: Global Point of Care Diagnostics Market by Segment (2013): Percentage Breakdown of Revenues for Commercial Labs, Hospital Labs, Point of Care and Self Testing (includes corresponding Graph/Chart)..............II-46 POC Testing Market..............II-47 Table 23: Global Point-of-Care Diagnostics Market by POC Tests (2015): Percentage Share Breakdown of Revenues for Blood Chemistry, Cardiac Markers, Cholesterol, Drug & Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, and Others (includes corresponding Graph/Chart) II-47 Development of Home Cholesterol Testing Kits II-47 Cholesterol and Other Cardiovascular Test Kits Offered by Select Companies..............II-48 Select Cholesterol Test Kits..............II-48 CardioChek Analyzer Starter Kit from PTS Panels II-48 EasyLife Cholesterol Test Strips II-48 CholesTrak Home Test Kit 2 ea II-48 Easylife Glucose, Uric Acid, Cholesterol Test Kit II-49 Accurate Home Test Kit..............II-49 Best Home Complete HDL, Lipid Panel LDL, and Triglycerides Test Kit.............. II-49 PRIMA 2-in-1 Home Test/Meter for Cholesterol and Triglycerides II-49 Cardio Chek Deluxe.............. II-49 Cholestrak Home Testing Kit for Total Cholesterol II-49 Cardio Chek Starter from PTS Panels II-49 LifeSign DietMate..............II-50 EasyLife Test Meter Kit for Cholesterol, Hemoglobin, and Glucose II-50 Cardiocheck Blood Testing Kit II-50 Best Home Complete Cholesterol Test II-50 Prima 3-in-1 Home Test..............II-50 Best Home Testing Kit for Cholesterol, Tot, HDL, LDL, and Triglycerides.............. II-50 Portable CardioCheck Blood Test System 1 ea II-51 Cardio Check Refil Kits..............II-51 Roche Diagnostics' Accurate Plus System II-51 LifeDesign DietMate—a Handheld Computer for Cholesterol, Hypertension, and Weight Control II-51

7. CHOLESTEROL CONTROL & TREATMENT MODALITIES II-52 Prevention is better than Cure II-52 Dietary Therapy.............. II-52 Healthy Diet.............. II-52 Exercises.............. II-53 Drug Therapy.............. II-53 Classification of Cholesterol Lowering Drugs II-53 Bile Acid Sequestrants..............II-53 Nicotinic Acid.............. II-53 HMG CoA Reductase Inhibitors (Statins) II-54 Other Drugs (Fibric Acids and Probucol) II-54 Testing After Commencing Drug Therapy II-54

8. PRODUCT INTRODUCTIONS..............II-55 Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma Ceramides II-55 CODIX Introduces SelexOn™..............II-55

9. RECENT INDUSTRY ACTIVITY..............II-56 Sinocare Acquires PTS Diagnostics II-56 LabCorp Acquires LipoScience..............II-56 PTS Switches Name to Chek Diagnostics II-56 LipoScience Parts Ways with Health Diagnostics II-56 Miraculins and Citizen Doctor Sign Distribution Deal II-56 Akers Biosciences Signs Distribution Deal for Rapid Tests in Australia, Singapore & Middle East II-56

10. FOCUS ON SELECT PLAYERS..............II-57 Abbott Diagnostics, Inc. (US)..............II-57 AccuTech, LLC (US)..............II-57 Alere Inc. (US).............. II-58 Beckman Coulter, Inc. (US)..............II-58 Home Access Health Corporation (US) II-59 PTS Diagnostics (US)..............II-59 Roche Diagnostics (US)..............II-60 Siemens Healthineers (Germany) II-60

11. GLOBAL MARKET PERSPECTIVE..............II-62 Table 24: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart).............. II-62

Table 25: World Historic Review for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) II-63

Table 26: World 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-64 Market by Test Type.............. II-65 Table 27: World Recent Past, Current & Future Analysis for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) II-65

Table 28: World Historic Review for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-66

Table 29: World 14-Year Perspective for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-67

Table 30: World Recent Past, Current & Future Analysis for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-68

Table 31: World Historic Review for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) II-69

Table 32: World 14-Year Perspective for Apolipoprotein B Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-70

Table 33: World Recent Past, Current & Future Analysis for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-71

Table 34: World Historic Review for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) II-72

Table 35: World 14-Year Perspective for Other Cholesterol Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-73

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Outlook.............. III-1 Surge in CVD Incidence - Major Growth Factor III-1 Table 36: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).............. III-1

Table 37: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)..............III-2

Table 38: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)..............III-2 Ageing Population - Vital Demography III-2 Table 39: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart) III-3 The Risk of CVD in Chronic Conditions to Drive Testing Market III-3 Opportunity Indicators..............III-4 Table 40: Obesity Prevalence in US Adults by Type of Obesity (2015) (includes corresponding Graph/Chart) III-4

Table 41: Obesity Prevalence in the US by Age Group (2015) (includes corresponding Graph/Chart) III-4

Table 42: Obesity Prevalence in the US by Percentage Annual Income Level of Adult Population (2015) (includes corresponding Graph/Chart) III-4

Table 43: US Diabetics Population (2010-2030): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart) III-5

Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart) III-5

Table 45: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Age Groups (includes corresponding Graph/Chart) III-6

Table 46: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Ethnic Group (includes corresponding Graph/Chart) III-6 Increasing Cardiovascular Ailments Drive Sales of Home Test Devices.............. III-7 Prospects and Challenges for Self-Testing Healthcare Devices Market.............. III-7 Regulatory Changes Support Self-Testing III-7 Challenges.............. III-8 Cholesterol POCT Market: An Overview III-8 Cholesterol Testing - NCEP Recommendations Spurs Potential III-9 The Rx-to-OTC Switch Scenario..............III-9 Electronic Health Records..............III-9 Accountable Care Organizations III-10 Managed Care Organizations..............III-10 Changing Care Settings..............III-10 Opportunities for Consumer Self Testing III-10 Regulations in Self-Testing Market: Need for Change III-11 Expanding Role of HCPs - A Step to Strengthen Self-Testing Market.............. III-12 Innovations Drive the Usage of Cardiovascular Monitoring Systems.............. III-13 Sterols and Stanols: Cholesterol-Lowering Products III-13 Product Launches..............III-13 Strategic Corporate Developments III-13 Key Players.............. III-14 B.Market Analytics..............III-18 Table 47: US Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-18

Table 48: US Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-19

Table 49: US 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2020 & 2022 (includes corresponding Graph/Chart)..............III-20

2. CANADA.............. III-21 Market Analysis.............. III-21 Table 50: Canadian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-21

Table 51: Canadian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-22

Table 52: Canadian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-23

3. JAPAN.............. III-24 Market Analysis.............. III-24 Table 53: Japanese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2415 through 2422(includes corresponding Graph/Chart)..............III-24

Table 54: Japanese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-25

Table 55: Japanese 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2020 & 2022 (includes corresponding Graph/Chart) III-26

4. EUROPE.............. III-27 A.Market Analysis.............. III-27 Current & Future Analysis..............III-27 Innovative Healthcare Policies and Guidelines to Mitigate Cardio Vascular Diseases and High Cholesterol Patients III-27 Europe's Cholesterol Problem Needs Serious Attention III-27 EU's Reluctance to Act..............III-28 Screening Children for Familial Hypercholesterolemia (FH) III-28 EU-wide Campaigns.............. III-29 B.Market Analytics..............III-30 Table 56: European Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-30

Table 57: European Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-31

Table 58: European 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-32

Table 59: European Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-33

Table 60: European Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-34

Table 61: European 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-35

4a. FRANCE.............. III-36 Market Analysis.............. III-36 Table 62: French Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-36

Table 63: French Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-37

Table 64: French 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-38

4b. GERMANY.............. III-39 A.Market Analysis.............. III-39 Outlook.............. III-39 Key Player.............. III-39 B.Market Analytics..............III-40 Table 65: German Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-40

Table 66: German Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-41

Table 67: German 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-42

4c. ITALY.............. III-43 Market Analysis.............. III-43 Table 68: Italian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-43

Table 69: Italian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-44

Table 70: Italian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-45

4d. THE UNITED KINGDOM..............III-46 Market Analysis.............. III-46 Table 71: UK Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-46

Table 72: UK Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-47

Table 73: UK 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-48

4e. SPAIN.............. III-49 Market Analysis.............. III-49 Table 74: Spanish Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-49

Table 75: Spanish Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-50

Table 76: Spanish 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-51

4f. RUSSIA.............. III-52 Market Analysis.............. III-52 Table 77: Russian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-52

Table 78: Russian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-53

Table 79: Russian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-54

4g. REST OF EUROPE.............. III-55 A.Market Analysis.............. III-55 Outlook.............. III-55 Product Launch.............. III-55 B.Market Analytics..............III-56 Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-56

Table 81: Rest of Europe Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-57

Table 82: Rest of Europe 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-58

5. ASIA-PACIFIC.............. III-59 A.Market Analysis.............. III-59 The Largest Market Worldwide III-59 B.Market Analytics..............III-60 Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-60

Table 84: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-61

Table 85: Asia-Pacific 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-62

Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-63

Table 87: Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-64

Table 88: Asia-Pacific 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-65

5a. CHINA.............. III-66 A.Market Analysis.............. III-66 Outlook.............. III-66 Strategic Corporate Development III-66 B.Market Analytics..............III-67 Table 89: Chinese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-67

Table 90: Chinese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-68

Table 91: Chinese 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-69

5b. INDIA.............. III-70 A.Market Analysis.............. III-70 Outlook.............. III-70 Corporate Development..............III-70 B.Market Analytics..............III-71 Table 92: Indian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-71

Table 93: Indian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-72

Table 94: Indian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-73

5c. REST OF ASIA-PACIFIC..............III-74 A.Market Analysis.............. III-74 Outlook.............. III-74 B.Market Analytics..............III-74 Table 95: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-74

Table 96: Rest of Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-75

Table 97: Rest of Asia-Pacific 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-76

6. LATIN AMERICA.............. III-77 Market Analysis.............. III-77 Table 98: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart) III-77

Table 99: Latin American Historic Review for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-78

Table 100: Latin American 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for Brazil, and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-79

Table 101: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-80

Table 102: Latin American Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-81

Table 103: Latin American 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-82

6a. BRAZIL.............. III-83 Market Analysis.............. III-83 Table 104: Brazilian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-83

Table 105: Brazilian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-84

Table 106: Brazilian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-85

6b. REST OF LATIN AMERICA..............III-86 Market Analysis.............. III-86 Table 107: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-86

Table 108: Rest of Latin America Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-87

Table 109: Rest of Latin America 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-88

7. REST OF WORLD.............. III-89 Market Analysis.............. III-89 Table 110: Rest of World Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-89

Table 111: Rest of World Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart) III-90

Table 112: Rest of World 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-91

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 29

The United States (23) Canada (1) Japan (1) Europe (2) - Germany (1) - The United Kingdom (1) Asia-Pacific (Excluding Japan) (2)

Read the full report: http://www.reportlinker.com/p04484194-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cholesterol-testing---clinical-diagnostics-300385056.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Home Medical Equipment Technologies Market Analysis & Trends - Industry Forecast to 2025
2. Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
3. Global Audiological Devices - Medical Equipment & Supplies
4. Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024
5. Continuous Glucose Monitoring Systems Market, 2022: Global Market Expected to Grow at CAGR of 24.10% - Research and Markets
6. Global Thrombectomy Devices Market Growth of 5% (2016-2020) - By Product Type, Indication & End Users - Research and Markets
7. Global Robotic Surgery Market (2016-2020) - By Product Type, Application, Volume & End User - Research and Markets
8. Global $310 Million Dental 3D Scanners Market Assessment & Forecasts, 2020 - Research and Markets
9. ArisGlobal verzeichnet eine wachsende Kundenbasis für die Arzneimittelsicherheits- und Risikomanagementplattform agBalance
10. ArisGlobal Wins Growing Client Base for Drug Safety and Risk Management Platform agBalance
11. Global Thermoform Packaging Market to hit US$57.6 Billion by 2024; Cost Effectiveness of Thermoform Packaging Products Raises Adoption - TMR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):